Dr. Kevin Hay

Biography

Kevin Hay is a Clinician Scientist at the University of Calgary and the Charbonneau Cancer Institute. He completed his Master of Science in Immunology at the University of Manitoba in 2008 and earned his MD in 2011. Following his medical education, Dr. Hay completed a residency in Internal Medicine in 2014 and a clinical fellowship in Haematology in 2016 at the University of British Columbia, where he was awarded a scholarship for the Clinician Investigator Program and pursued a postdoctoral fellowship in cellular immunotherapy at the Fred Hutchinson Cancer Research Center in Seattle. In 2019, he took a position with the Leukemia/BMT Program at UBC, serving as Director of the Clinical Cell Therapy Laboratory and developing a research program in CAR-T cell therapy. Since moving to the University of Calgary in 2023, Dr. Hay continues to serve as Medical Director of the Conconi Family Immunotherapy Laboratory. His research primarily focuses on the translation of cellular immunotherapy, especially CAR-T cell therapy, and includes correlative studies with patients who have received these therapies to enhance efficacy and reduce toxicity. Key highlights of his research include contributions to understanding unique toxicities associated with CD19 CAR-T cell therapy and overseeing the development of point-of-care CAR-T cell manufacturing in Canada.

Research Interests

Experience